Table 4.
Characteristic | OR (95% CI) | P value |
---|---|---|
Univariate analysis for predictors of antibiotic-resistant infection | ||
Demographic variables | ||
Age | 1.02 (0.97–1.07) | .48 |
Medications and comorbidities | ||
On β-blockers | 1.4 (0.5–3.6) | .49 |
On proton pump inhibitors | 2.3 (0.8–6.2) | .11 |
Diabetes mellitus | 1.2 (0.5–3.2) | .71 |
Mode of infection acquisition and antibiotic exposure history | ||
Nosocomial infection | 10.3 (3.3–32.1) | .001 |
Antibiotics within 30 d of bacterial infection (any antibiotic vs no antibiotic) | 7.7 (2.2–26.1) | .001 |
Antibiotics within 30 d of bacterial infection | ||
No antibiotic | 1.0 | Reference category |
Oral nonabsorbed antibiotics | 0.7 (0.1–4.2) | .7 |
Systemic antibioticsa | 32 (7–144) | .001 |
Laboratory test results and severity of liver disease | ||
Albumin level, g/dL | 2.2 (1.0–4.6) | .04 |
White blood cell count | 1.03 (0.96–1.11) | .44 |
Child–Pugh score | 1.8 (1.2–2.6) | .002 |
MELD score | 1.08 (1.03–1.14) | .004 |
Multivariate analysis for predictors of antibiotic-resistant infection | ||
Antibiotic use within 30 d of bacterial infection | ||
No antibiotic | 1 | Reference |
Oral nonabsorbed antibiotic | 0.4 (0.04–2.8) | .32 |
Systemic antibioticsa | 13.5 (2.6–71.6) | .002 |
Nosocomial infection | 1.6 (0.2–9.9) | .6 |
MELD | 1.05 (0.96–1.15) | .3 |
Albumin level, g/dL | 1.5 (0.6–4.1) | .4 |
Some patients also received oral nonabsorbed antibiotics.